Advertisement
Clinical

The Cancer Letter wins investigative, design awards

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
DOWNLOAD PDFTABLE OF CONTENTS

The Cancer Letter won four 2018 Dateline Awards from the Washington, D.C. Chapter of the Society of Professional Journalists:

  • Investigative Journalism, Newsletter/Trade Publications, first place, for “A Coup D’état, and a $12M Deal at the University of Utah,” by Paul Goldberg and Matthew Ong (The Cancer Letter, April 21, April 28, May 5, 2017)

  • Front Page Design, Newsletter/Trade Publications, first place, for “43 Years Later: A Redesign of The Cancer Letter,” By Jacqueline Ong and Katherine Goldberg

  • Photo Illustration, Newsletter/Trade Publications, first place, for “Oncology as Art in 2017,” by Katherine Goldberg

  • Series, Newsletter/Trade Publications, finalist, for “Real-World Data: A New Frontier in Cancer Bioinformatics,” by Matthew Ong (The Cancer Letter, June 2, June 9, 2017)

This is the first time The Cancer Letter has won design awards. Every week, our illustrator, Katherine Goldberg, offers a smart, irreverent take on events in oncology. Jacqueline Ong, our designer, undertook a snazzy redesign of the PDF version of The Cancer Letter.

Here are a few of The Cancer Letter’s award-winning covers:

Advertisement
Advertisement
Table of Contents
Advertisement
Advertisement

YOU MAY BE INTERESTED IN

Guest Editorial

Rathmell: We must support our junior colleagues
“Empathy and listening is a key place to start”

Just consider for a minute if this was the first year of running your lab, if you were on the job market as a physician or scientist right now, if you were a resident contemplating a career in cancer research after fellowship, if you were a graduate student or postdoc, if you were an undergraduate or a technician who was looking toward graduate school.
By W. Kimryn Rathmell
Guest Editorial

Weill Cancer Hub East to investigate connections between metabolism and anti-tumor immunity
Weill Cornell, Rockefeller, Princeton and the Ludwig Institute for Cancer Research showcase the power of collaboration

The immune system can be a powerful tool to control cancer. Immune cells within our body detect cancer cells and release payloads that kill them. Transformative science in the last decade has led to the development of therapies that enhance the ability of our immune cells to carry out this function. These therapies, including checkpoint blockade and CAR-T cells, have been lifesaving for many patients that before had untreatable cancer. But, sadly, a majority of patients with advanced solid tumors still succumb to their disease. 
By Jedd D. Wolchok, Joshua D. Rabinowitz and Sohail Tavazoie
Advertisement
Advertisement